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The renal thick ascending limb (TAL) and distal
convoluted tubule (DCT) play central roles in salt
homeostasis and blood pressure regulation. An
emergingmodel suggests that bumetanide- and thia-
zide-sensitive NaCl transporters (NKCC2 and NCC)
along these segments are phosphorylated and acti-
vated by WNK kinases, via SPAK and OSR1. Here,
we show that a kidney-specific SPAK isoform, which
lacks the kinase domain, inhibits phosphorylation of
NCC and NKCC2 by full-length SPAK in vitro.
Kidney-specific SPAK is highly expressed along the
TAL, whereas full-length SPAK is more highly ex-
pressed along the DCT. As predicted from the differ-
ential expression, SPAK knockout in animals has
divergent effects along TAL and DCT, with increased
phosphorylated NKCC2 along TAL and decreased
phosphorylated NCC along DCT. In mice, extracel-
lular fluid volume depletion shifts SPAK isoform
abundance to favor NaCl retention along both seg-
ments, indicating that a SPAK isoform switch modu-
lates sodium avidity along the distal nephron.
INTRODUCTION
Arterial pressure and extracellular fluid (ECF) volume are deter-
mined largely by renal NaCl excretory capacity. A key signaling
pathway that modulates NaCl reabsorption and K+ secretion
involves WNK kinases interacting with SPAK and OSR1.
These kinases act along the distal nephron to modulate the
bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2) and
the thiazide-sensitive NaCl cotransporter (NCC). The STE20
(sterile 20)-like kinases SPAK (STE20- and SPS1-related
proline/alanine-rich kinase) andOSR1 (oxidative stress response
kinase-1, abbreviated OXSR1 in GenBank) contribute to ion
homeostasis and cell volume control (Delpire and Gagnon,
2008). In mammalian cells, SPAK phosphorylates and activates
the cation chloride cotransporters, NKCC1, NKCC2, and NCC,
under hyperosmotic or hypotonic low-Cl conditions (Richard-
son et al., 2011); members of the WNK family act upstream of352 Cell Metabolism 14, 352–364, September 7, 2011 ª2011 ElsevieSPAK,phosphorylating itwithin theT-loopof thecatalytic domain
and within a C-terminal noncatalytic region (Vitari et al., 2005).
WNK kinase effects on SPAK activity may contribute to human
hypertension, as mutations in genes encoding WNK 1 and 4
cause the human disease familial hyperkalemic hypertension
(FHHt, also known as pseudohypoaldosteronism II, or Gordon
Syndrome) (Wilson et al., 2001), a disease associated with
increased NCC activity (Mayan et al., 2002).
These data have led to a linear model of WNK/SPAK-OSR1/
NKCC2-NCC signaling in which WNKs phosphorylate and acti-
vate SPAK-OSR1, which phosphorylates and activates NCC
and NKCC2 (Richardson and Alessi, 2008). This suggests that
SPAK-OSR1 inhibition should suppress the activity of both
NCC and NKCC2 (Richardson et al., 2011). Yet recent data
from animal models are not entirely consistent with this view.
Alessi and colleagues (Rafiqi et al., 2010) generated mice that
express a SPAK mutant that cannot be activated. The animals
exhibited reductions in phosphorylated (activated) NCC and
NKCC2 and were substantially hypotensive. In contrast, Yang
and colleagues reported that, in SPAK knockout animals, there
was less phosphorylated NCC, but more phosphorylated
NKCC2 in kidney; the salt-wasting phenotype in these mice
was also milder. Thus, deletion of SPAK and inactivation of
SPAK have similar effects on NCC, but divergent effects on
NKCC2; this discrepancy was pointed out recently in an editorial
(Rodan and Huang, 2010). Here, we show that renal SPAK
comprises several structurally and functionally dissimilar iso-
forms, at least one of which is inhibitory rather than stimulatory.
These isoforms are differentially expressed along the TAL and
DCT and are regulated according to ECF volume. The data
provide an explanation for the discrepant results described
above; suggest a reason that two very similar kinases, OSR1
and SPAK, are present in the same kidney epithelial cells; and
unravel a mechanism for NaCl and blood pressure homeostasis.
RESULTS
Renal SPAK Products Include Antagonistic Isoforms
Typically, SPAK is believed to be a full-length kinase (Delpire and
Gagnon, 2008), but additional forms have been described
(Piechotta et al., 2003). Full-length SPAK is expressed promi-
nently in brain and most other tissues (Rafiqi et al., 2010); on
immunoblots from kidney, however, nearly all SPAK runs asr Inc.
Figure 1. Characterization of SPAK Isoforms
(A) Immunoblot of mouse kidney and brain, probed with an anti-SPAK antibody recognizing a carboxyl-terminal domain. Brain SPAK runs predominantly near
59 kDa, whereas kidney SPAK runs primarily as two smaller bands, labeled SPAK2 and KS-SPAK. Tissue from SPAK knockout (KO) animals (see Figure 3) is
shown as a control.
(B) 50 RACE, using primers directed to exon 6 and 10. Note faint bands running as expected for full-length SPAK and dark bands running representing KS-SPAK. A
positive control (Cont) is also shown.
(C) RT-PCR on a multitissue panel (E, whole embryo), using forward primer to exon 5a and reverse primer to exon 10, shows that KS-SPAK expression is almost
exclusively restricted to kidney. GAPDH serves as a positive control and water as a negative control.
(D) Top panel shows transcripts showing the alternative translation initiation sites (top) and the alternative transcript showing exon 5a and the third ATG (bottom).
Bottom panel shows protein products derived from these transcripts, including the PAPA box, and the kinase domain, with T243within the T loop, the Smotif, and
the CCT domain.
(E) Immunoblot of brain and kidney probedwith an anti-N-SPAK antibody. Tissue fromSPAKKOmice (see Figure 3) is included as a control. Note the faint band in
WT kidney. Other bands are nonspecific, as indicated by their presence in the KO animals.
(F) In vitro kinase assay; NKCC2 was incubated with low-activity SPAK (T243A) or constitutively active SPAK (T243E). Effects of increasing KS-SPAK (triangle) on
SPAK-dependent NKCC2 phosphorylation (pNKCC2) are shown. Coomassie (lower panel) shows protein products, with * indicating that a contaminant
(appearing even in the first lane, when SPAK was not added) runs at the same apparent size as SPAK. Note that inactive SPAK T243A (TA) migrates at a different
size compared with constitutively active SPAK T243E (TE).
(G) Kinase activity in HEK cells transfected with NCC. Increasing KS-SPAK (triangle) decreases total and phosphorylated NCC. Phosphorylated NCC from cells is
the diffuse band (pNCC, not the nonspecific band, NS). Note that KS-SPAK runs as a doublet, suggesting posttranslational modification. Kidney tissue is shown
at the right, with fully glycosylated, mature NCC marked with *.
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SPAK Isoform Switch in the Kidneysmaller products (Rafiqi et al., 2010). Furthermore, SPAK precip-
itated from kidney is largely devoid of kinase activity (Rafiqi et al.,
2010). Here (Figure 1A), we confirmed that SPAK in brain runs as
expected for the full-length product (60 kDa), whereas kidney
SPAK runs primarily as faster-migrating bands. Piechotta and
colleagues (Piechotta et al., 2003) showed that SPAK can be
generated from two translation initiation sites, one 115 base
pairs downstream from the full-length SPAK START codon.
This smaller product lacks the entire PAPA box and was pre-
dicted to be kinase defective (Piechotta et al., 2003); we term it
SPAK2. Immunoblots from kidney and other tissues show
a band of a size near to that predicted for the second translationCell Meinitiation site (Figure 1A) (Rafiqi et al., 2010). In addition, however,
a smaller band appears prominently in kidney (Figure 1A); this
band has not been observed in other tissues (Figure 1A) (Rafiqi
et al., 2010).
Our observation of at least three SPAK products on renal
immunoblots suggested the existence of either yet another
alternative translation START or a splice variant. To address
this possibility, we performed 50 and 30 RACE, using total RNA
from mouse kidney. The major product identified in kidney
corresponded to a transcript that differs from that predicted
for the full-length SPAK, which was a minor amplified product
(Figure 1B). The smaller transcript was isolated using primerstabolism 14, 352–364, September 7, 2011 ª2011 Elsevier Inc. 353
Figure 2. Sites of SPAK Expression in Kidney
(A) SPAK (here detected with an anti-N-SPAK antibody) is expressed along both the TAL and the DCT, as indicated by colocalization with NCC and anti-NKCC2.
(B) Sites of expression of full-length SPAK (detected with anti-N-SPAK) and total SPAK (detected with anti-C-SPAK). Transitional segments containing both TAL
and DCT are shown, as determined using anti-NCC and anti-NKCC2 antibodies. Note that full-length SPAK expression is higher along DCT than TAL, whereas
total SPAK expression is higher along TAL than DCT.
(C) Total SPAK immunoblot of medullary and cortical tissue. Note that most cortical SPAK is the full-length isoform (SPAK), whereas KS-SPAK and SPAK2 are
more highly expressed in medulla.
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SPAK Isoform Switch in the Kidneytargeting both exons 6 and 10 and contained a distinct first exon
(exon 5a, see Figure S1 for sequence), located within intron 5–6,
about 17 kb upstream of exon 6, in the genomic sequence. The
same transcript has been identified previously as an expressed
sequence tag (EST) in mousemammary tumor (NCBI accessions
BL110429.1 and AQ988594.1), but based on western blotting
data (Rafiqi et al., 2010), its expression pattern appears largely
restricted to kidney. To confirm this, we performed RT-PCR
using primers specific for the novel transcript-specific exon 5a
and the shared exon 10. As shown in Figure 1C, the transcript
was not detected at substantial levels in other tissues; thus, we
have termed it kidney-specific SPAK (KS-SPAK) (GenBank
accession JN368425). Seven out-of-frame START codons are
present in exons 5a and 6 prior to the first in-frame START
(equivalent toM251 in full-length SPAK), so the proposed protein
does not contain any novel amino acid sequence, but is rather
a truncation of full-length SPAK (Figure 1D).
Both KS-SPAK and SPAK2 are predicted to lack the N
terminus (Figure 1D), which is present in the full-length protein.
To confirm the identity of these products, we used antibodies
directed against the SPAK N terminus. Figure 1E confirms that
full-length SPAK, but not SPAK2 or KS-SPAK, is recognized by
the antibody directed toward an amino-terminal epitope. Full-
length SPAK is prominent in the brain (and other tissues, data
not shown); in kidney, however, its abundance is substantially
lower. Thus, much of renal SPAK lacks an amino terminus.
When apparent molecular weights were examined at higher354 Cell Metabolism 14, 352–364, September 7, 2011 ª2011 Elsevieresolution (Figure S2), the three renal SPAK forms ran somewhat
larger than their predicted sizes. Furthermore, when expressed
in HEK293 cells by transfection, the three SPAK isoforms ran
close to, but not precisely at, the sizes observed in kidney. These
data suggest that SPAK isoforms undergo significant posttrans-
lational modification in vivo.
KS-SPAK retains its conserved C-terminal (CCT) domain,
which has been shown to bind to NKCC2, to participate in phos-
phorylation and activation (Richardson et al., 2011). Further-
more, synthetic kinase-dead SPAK mutants exhibit dominant-
negative effects on wild-type (WT) SPAK (Dowd and Forbush,
2003). Thus, we tested whether KS-SPAK might inhibit SPAK
activity; in vitro, KS-SPAK inhibited phosphorylation of both
NKCC2 and NCC by SPAK, rendered constitutively active
(T243E), in a dose-dependent manner (Figures 1F and S3). To
confirm the relevance of this observation in mammalian tissue,
we used HEK293 cells, which express SPAK primarily as the
kinase-active full-length form (see Figure 1G). The cells were
transfected with both NCC and KS-SPAK. Cotransfection with
KS-SPAK led not only to a dose-dependent decrease in phos-
phorylated NCC, but also to a substantial decrease in total
NCC abundance. (Figure 1G).
SPAK Isoforms Are Differentially Expressed
along TAL and DCT
Figure 2A shows that SPAK is expressed along both the DCT
and the TAL, where it colocalizes with both NCC and NKCC2;r Inc.
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SPAK Isoform Switch in the Kidneyexpression was not detected in other segments. To determine
whether the full-length SPAK is expressed equally along TAL
and DCT, additional immunofluorescence compared transitional
nephron segments, using both anti-N-SPAK and anti-C-SPAK
antibodies. Figure 2B shows that full-length SPAK is modestly
expressed along the TAL, but is more apparent along the DCT.
In contrast, total SPAK (comprising both full-length and trun-
cated forms and detected using the anti-C-SPAK antibody)
appears to be much more abundant along the TAL than the
DCT. Immunofluorescence is not quantitative, so we examined
immunoblots of kidney cortex and medulla. We reasoned that
medulla contains only TAL, whereas cortex contains both DCT
and TAL. Figure 2C shows striking differences in SPAK isoform
expression; in cortex, SPAK is predominantly full length,
whereas in medulla, most SPAK is SPAK2 and KS-SPAK.
Together, these data suggest that SPAK along the DCT should
stimulate NCC transport, as the full-length, kinase-active form
predominates. In contrast, SPAK along the TAL should be inhib-
itory, as the predominant forms lacking the kinase domain can
inhibit SPAK activity.
SPAK Knockout Mice Display Salt-Sensitive
Hypotension and Electrolyte Imbalance
To test the hypothesis that SPAK forms exert opposite effects
on cation chloride cotransporter activity along the TAL and
DCT, we used SPAK knockout mice (Delpire and Gagnon,
2008; Geng et al., 2010). Due to the strategy used to generate
them, SPAK+/ mice (referred to hereafter as heterozygotes, or
HETs) cannot be distinguished from SPAK/ mice (referred to
hereafter as knockouts, or KOs) by PCR. Thus, we used all
offspring obtained fromHET intercrosses and performed pheno-
typic identification after completion of experimental maneuvers.
The genotypes of WT, HET, and KO mice were verified using
PCR, western blotting, and immunofluorescence (Figures 3A
and 3B).
To determine the role of SPAK in blood pressure regulation,
systolic blood pressure was measured by volume pressure-
recording tail plethysmography (Feng et al., 2008). When
consuming a control NaCl diet (0.49% NaCl), blood pressures
of the three groups did not differ (Figure 3C). Dietary NaCl restric-
tion (0.01%NaCl) for 7 days, however, reduced systolic pressure
significantly in SPAK KOmice (9.4 ± 2.1 mm Hg), but not in WT
and HET mice (Figure 3C).
To characterize electrolyte and renin-angiotensin-aldosterone
system (RAAS) status, whole blood from WT, HET, and KO
mice maintained on a standard diet was collected and immedi-
ately analyzed using an iSTAT blood chemistry analyzer (Table
S1). Compared with WT mice, KO mice did not display any
significant differences in whole blood electrolyte levels. In KO
mice, however, there was a trend toward hypokalemia (WT,
4.6 mmol/l versus KO, 4.2 mmol/l) and hypomagnesemia (WT,
0.96 mmol/l versus KO, 0.88 mmol/l). As expected, plasma renin
activity (PRA) was higher in KO than in WTmice, but aldosterone
levels were not (see Discussion). Finally, SPAK KO mice were
hypocalciuric, as shown by a significantly lower urinary calcium:
creatinine ratio than WT mice (WT, 0.52 ± 0.09 mg/mg versus
KO, 0.20 ± 0.04, p < 0.05) (see also Table S1). HETs were also
significantly hypocalciuric (0.29 ± 0.06, p < 0.05) compared
with WT mice.Cell MeMice were next subjected to manipulation of dietary electro-
lytes to aid identification of differences that were not apparent
on a standard diet. Severe restriction of dietary K+ resulted in
dramatic reductions in whole blood K+ in both WT and KO
mice (data not shown), so a more modest restriction was per-
formed (from 0.8% K+ to 0.08% K+). On this diet, whole blood
K+ was significantly lower in KO mice compared with WT mice
(Figure 3D). Hypocalciuria owing to NCC deletion or inhibition
has been proposed to result primarily from depletion of the
ECF volume (Nijenhuis et al., 2005). To determine whether die-
tary NaCl loading could overcome the hypocalciuric effects of
SPAK deletion, mice were salt loaded. In SPAK KOmice, urinary
calcium/creatinine remained lower, compared with WT mice,
even though urinary salt excretion rose to high levels, confirming
that the ECF volume was expanded; HETs displayed an interme-
diate response (Figure 3E). PRA was significantly higher in KO
mice on both normal and low-NaCl diet (Figure 3F). SPAK KO
mice displayed a normal stimulation of aldosterone secretion in
response to sodium restriction, but did not display a reduction
in response to salt loading (Figure 3G).
SPAK Deletion Stimulates NKCC2, but Inhibits NCC
To determine whether SPAK KO mice display abnormalities in
NKCC2 or NCC expression and activity, we performed immuno-
blot analysis of protein lysates from WT, HET, and SPAK KO
mice. On a standard NaCl diet, total NKCC2 expression did
not differ between WT and SPAK KO mice (Figures 4A and 4B),
but phosphorylated NKCC2 was increased substantially in the
SPAK KO animals (Figures 4A and 4B). These data were
confirmed by immunohistochemistry, which showed a marked
increase in phosphorylated NKCC2 abundance in SPAK KO
animals (Figure 4C).
In contrast, total NCC expression in SPAK KO mice was
dramatically reduced (by 90% versus WT mice) on a standard
NaCl diet (Figures 4D and 4E). To assess NCC activation status,
we examined phosphorylation at T53 (and, in some studies,
S71); the reduction in total NCC expression was matched by
a similar decrease in phosphorylated NCC (Figures 4D and
4E). While HETs displayed a reduction in total NCC, phosphory-
lated NCC was essentially normal, indicating a compensatory
effect in HETs (Figures 4D and 4E). Even after dietary salt restric-
tion (0.01% NaCl), the abundance of phosphorylated NCC
remained substantially reduced in SPAK KO animals (Figures
4D and 4E).
Yang and colleagues (Yang et al., 2010) reported that SPAK
KO mice exhibit substantial reductions in natriuretic response
to thiazides, with a preserved response to loop diuretics. To
confirm those results and test whether changes in NKCC2
and NCC abundance and phosphorylation have functional
consequences, the acute urinary Na+ excretion in response to
furosemide or hydrochlorothiazide (HCTZ) injection was deter-
mined. At baseline, urinary Na+ excretion during 3 hr was similar
in WT, HET, and SPAK KO mice (Table S1). Compared with WT
animals, the natriuretic response to furosemide was increased
in the SPAK KO animals, whereas the HCTZ response was
reduced (Figure 4F); thus, the ratio of furosemide/HCTZ-induced
natriuresis was significantly higher in the SPAK KO animals
compared with WT animals (p < 0.05), consistent with the
changes in phosphorylated NKCC2 and NCC.tabolism 14, 352–364, September 7, 2011 ª2011 Elsevier Inc. 355
Figure 3. Targeted Disruption of SPAK and SPAK Isoforms
(A) PCR and immunoblot analysis to identify WT, HET, and KO mice. In this low-penetrated blot, full-length SPAK is not evident.
(B) Immunofluorescent analysis of kidney sections revealed expression of SPAK in WT and HET mice and confirmed ablation of SPAK in SPAK KO mice.
(C) Systolic blood pressure on normal- (Nl) NaCl intake diet (0.49% NaCl) and after 10 days on a low-NaCl intake diet (0.01% NaCl). Data are plotted as lines for
individual mice on each diet; the mean systolic pressures ± SEM are shown as closed circles. Systolic pressure was reduced in SPAK KO mice (Mann-Whitney
test) after NaCl restriction.
(D) On a normal- (Nl) K+ intake diet (0.8%K+), whole blood K+ did not significantly differ betweenWT and KOmice.Whole blood K+was significantly lower in SPAK
KO mice on a K+-restricted diet than in WT mice (Mann-Whitney test). Values here are slightly higher than in Table S1, as the blood was obtained here by
saphenous puncture rather than cardiac puncture. Data are plotted as above.
(E) Effects of dietary NaCl intake on urinary calcium excretion, expressed as the ratio of calcium to creatinine. Data are mean ratio ± SEM, n = 8–14.
(F) Plasma renin activity (PRA) in SPAK KO mice on both low- and normal-NaCl-intake diets. Data are mean ± SEM, n = 4–6.
(G) Effects of SPAK KO and of dietary NaCl on aldosterone. Data are mean ± SEM n = 8–10 on normal-NaCl intake, 5–7 on high NaCl intake, and 5WT, 6 KO, and
13 HETs on low-NaCl intake.
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Figure 4. SPAK Deletion Increases Phosphorylated NKCC2 and Decreases Phosphorylated NCC
(A) Western blotting of kidney protein lysates revealed no change in total expression of NKCC2, but increased expression of phospho-NKCC2 (pT96, pT101) in
SPAK KO mice.
(B) Densitometry revealed that SPAK KO mice display a 4-fold increase in phospho-NKCC2 levels (±SEM, n = 4, p < 0.001, Mann-Whitney test).
(C) This was also apparent on immunofluorescent analysis of kidney.
(D) Total and p-NCC (pT53) expression is reduced in NCC KO mice on normal and low-salt diet.
(E) Total and p-NCC (±SEM) were reduced by 90% relative to b-actin (n = 3, p < 0.05 versus WT, Mann-Whitney test). Similar results were seen in salt-deprived
animals.
(F) Natriuretic effects (±SEM) of furosemide tended to be greater, and of hydrochlorothiazide (HCTZ) less, in KO compared to WTmice. The differential response
between groups was significant. (n = 6 and 5 in WT and KO, p < 0.05, Mann-Whitney test.)
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SPAK Isoform Switch in the KidneySPAK Deletion Reduces DCT Mass, but Does Not Shift
NCC from the Apical Membrane
To determine whether SPAK KO reduced NCC at the apical
membranes preferentially, kidney sections were examined by
immunofluorescence and by immunogold electron microscopy.
The results confirmed that SPAK KO reduced total NCC abun-
dance, as well as the abundance of NCC phosphorylated at
T53 and S71 (Figures 5A and 5B). Despite the reduction, both
total and phosphorylated NCC remained predominantly at the
apical membrane; SPAK KO did not lead to an intracellular shift
(Figure 5C). Apical expression is clearly a requirement for NCC to
transport NaCl into the cell; these data suggest that NCC traf-
ficking to and residence in the plasma membrane is not affected
substantially by SPAK phosphorylation, a finding consistent with
in vitro data (Glover et al., 2009). Even in the SPAK KO animals,
phosphorylated NCCwas restricted to the apical membrane and
did not appear in intracellular vesicles (Figure 5D).
Low-power immunohistochemistry suggested that the
number of DCT profiles is reduced in SPAK KOmice (Figure 5E).
Quantitative analysis confirmed that the fractional DCT volume
(determined as the fraction of tubules that express NCC) is
approximately 50% lower in SPAK KO mice compared to
WT (Figure 5F). Thus, a substantial portion of the reduction inCell Metotal and phosphorylated NCC reflects underdevelopment of
the DCT.
OSR1 Expression Is Maintained in SPAK KO Animals
The observation that deletion of SPAK increases NKCC2 phos-
phorylation suggests that SPAK (presumably KS-SPAK) along
the TAL is inhibiting a kinase at baseline, yet the kinase cannot
be SPAK alone, as NKCC2 phosphorylation is increased
even though all SPAK is absent. OSR1 and SPAK share the
ability to phosphorylate cation chloride cotransporters, and
both proteins are expressed in kidney (Rafiqi et al., 2010). To
confirm that OSR1 expression patterns mirror those of SPAK,
we examined OSR1 abundance in WT and SPAK KO animals
by immunofluorescence. The results confirm that OSR1 is ex-
pressed along the TAL (Figure 6A) and DCT (Figure 6B) in a distri-
bution resembling that of SPAK. OSR1 expression was not
affected substantially by SPAK deletion (Figure 6C); it remained
predominantly near the apical membrane, close to NCC and
NKCC2 (Figures 6A and 6B). Of note, in DCT profiles of SPAK
KO mice, OSR1 did exhibit a more punctate distribution than it
did inWT animals.We also confirmed (Figure 6C) the observation
of Yang and colleagues (Yang et al., 2010) that the abundance of
phosphorylated OSR1 is increased by SPAK KO (approximatelytabolism 14, 352–364, September 7, 2011 ª2011 Elsevier Inc. 357
Figure 5. Apical Membrane Localization of NCC Is Unchanged in SPAK KO Mice, but Fractional Volume of the DCT Is Reduced
(A and B) Immunofluorescence on kidney sections using antibodies against total NCC (A and B), pT53 NCC (A), and pS71 NCC (B) revealed that total and p-NCC
apical membrane distribution is not altered in SPAK KO mice, despite a 90% reduction in total and p-NCC expression levels.
(C and D) Immunogold electron microscopy against total and p-NCC revealed that the relative abundance of total NCC (C) and pS71 (D) in the apical membrane
versus inside of cells was not altered by SPAK KO. Note that while total NCC is detected at both apical and subapical regions, pS71 NCC is expressed only on the
apical surface. Arrows indicate apical localization, and arrowheads indicate subapical localization.
(E) Low-power images of kidney sections stained for NCC expression (brown staining) by immunohistochemistry suggest fewer DCT segments.
(F) Quantification of the fractional volume of the DCT (DCT Fx volume) confirmed a 54% reduction in DCT in SPAK KO mice (mean ± SEM, n = 4).
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important function of KS-SPAK along the TAL is to inhibit OSR1.
In support of this model, we found that KS-SPAK is capable of
inhibiting the ability of OSR1 to phosphorylate NKCC2 in vitro
(Figure 6D).
Extracellular Volume Depletion Generates a SPAK
Isoform Switch
We next tested the hypothesis that dietary NaCl intake alters the
relative abundance of SPAK products. Figure 7A shows that die-
tary NaCl restriction reduced the abundance of KS-SPAK (the
inhibitory form) while increasing the abundance of longer
(presumably stimulatory) forms. Further, the activated SPAK iso-
forms shifted to a higher apparent molecular weight, an effect
described previously (Anselmo et al., 2006). It should also be
noted that additional, undefined forms of SPAK appeared
following dietary NaCl restriction. These results suggested that
mild depletion of the ECF volume, as induced by dietary restric-
tion, was sufficient to effect this change. We confirmed this
hypothesis by comparing NCC KO animals with their WT
controls. Figure 7B shows that NCC KO animals exhibit a similar
SPAK isoform shift compared with their WT controls (quantified
in Figure S4). The animals also exhibit an increase in total and358 Cell Metabolism 14, 352–364, September 7, 2011 ª2011 Elseviephosphorylated NKCCs (Figure S5). In contrast, the pattern
and abundance of OSR1 do not appear to be affected by NCC
KO (Figure 7C).
DISCUSSION
SPAK, OSR1, and theWNK kinases interact in the distal nephron
to regulate NCC and NKCC2 activity, modulating salt and potas-
sium balance and arterial pressure. While it is now clear that
WNK kinases can phosphorylate and activate both SPAK and
OSR1 and that SPAK and OSR1 can activate and phosphorylate
NCC and NKCC2 (Richardson and Alessi, 2008), there is less
information about how these kinases interact to regulate salt
transport in animals. Here, we identified interactions between
previously unrecognized SPAK isoforms that modulate NCC
and NKCC2 in vivo. We determined that a KS-SPAK isoform
exerts inhibitory rather than stimulatory effects on NaCl trans-
port both in vitro and in vivo. Further, we show that loss of this
isoform accounts for the anomalous effects of SPAK KO on
NKCC2 activity. Finally, we showed that SPAK isoform abun-
dance is subject to substantial regulatory modulation; together,
these proteins form a WNK/SPAK-OSR1 signaling complex in
the distal nephron.r Inc.
Figure 6. Distribution and Expression of OSR1 in SPAK KO Mice
(A) OSR1, expressed along the TAL with NKCC2, is not affected by SPAK KO.
(B) OSR1 also expressed along the DCT with NCC; in SPAK KO mice, OSR1 expression appeared more punctuate than in WT mice.
(C) Immunoblot analysis of total expression of OSR1 revealed no substantial difference between WT and SPAK KO mice. Bottom panel shows, however, that
phosphorylated OSR1 was increased by SPAK KO (216% in SPAK KO, n = 3, p = 0.01).
(D) In vitro kinase assay; NKCC2was incubated with low-activity OSR1 (T185A) or constitutively active OSR1 (T185E). Effects of increasing KS-SPAK (triangle) on
OSR1-dependent NKCC2 phosphorylation (pNKCC2) are shown. Coomassie (below) shows protein products, with * representing a contaminant in the protein
prep that was present even when OSR1 was not included (first lane). Note that when OSR1 is included, the band becomes darker and runs as a subtle doublet.
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phorylating residues along their amino-terminal cytoplasmic
domains; SPAK and OSR1, in turn, can be activated by several
WNK kinases (Richardson and Alessi, 2008). Based upon these
properties and the documented expression of SPAK along
the TAL and DCT, it would be predicted that SPAK deletion
should impair NaCl reabsorption along both nephron segments,
generating a phenotype combining features of both Bartter and
Gitelman syndromes. Two mouse models have been consistent
with this view (Table S2). First, SPAKT243A/T243A knockin mice,
which express a SPAK protein devoid of kinase activity, have
lower arterial pressure and less phosphorylated NKCC2 and
NCC than WT mice (Rafiqi et al., 2010). Second, mice deficient
in SORLA (sorting-protein-related receptor with A-type repeats),
which is expressed along the TAL and DCT, display a phenotype
with features of mild type I Bartter Syndrome (in which NKCC2
has been disrupted), including excessive urinary K+ and Ca2+Cell Meexcretion (Reiche et al., 2010). In SORLA KO mice, levels of total
SPAK were unchanged, but SPAK shifted away from NKCC2 to
a more subapical region with reductions in phosphorylated
NKCC2.
In contrast, the results of Yang and colleagues (Yang et al.,
2010) and the current results both show that SPAK KO increases
the phosphorylation (and activity) of one transporter (NKCC2)
while reducing the phosphorylation of the other (NCC). We
considered several explanations to account for these differ-
ences. First, ECF volume depletion, owing to NCC inactivity,
might have stimulated NKCC2 phosphorylation secondarily,
independent of SPAK. Yet ECF volume depletion per se does
not seem to be the dominant cause, as SPAKT243A/T243A mice,
which exhibit the same or even greater ECF fluid volume deple-
tion, display less, not more, phosphorylated NKCC2 (Rafiqi et al.,
2010; Rodan and Huang, 2010). A second possibility was that
SPAK deletion might somehow have led to compensatorytabolism 14, 352–364, September 7, 2011 ª2011 Elsevier Inc. 359
Figure 7. SPAK Isoform Shift
(A) C-SPAK immunoblot comparing WT mice on a normal and restricted-NaCl diet. Note the increase in KS-SPAK and SPAK2, the decline in KS-SPAK abun-
dance, and the appearance of additional products.
(B) C-SPAK immunoblot comparing WT mice on a normal diet with NCC KO mice on a normal diet. Qualitatively similar changes as in (A) were observed.
(C) OSR1 immunoblot comparing WT mice and NCC KO mice, showing no changes comparable to those for SPAK.
(D) Model of SPAK and OSR1 actions along the distal nephron. Model is simplified by assuming that all SPAK in DCT is full length whereas most SPAK in TAL is
truncated. Active kinases are labeled in green, while the inactive KS-SPAK is labeled in red. KS-SPAK in TAL inhibits SPAK and OSR1 in WT animals. SPAK KO
leads to the changes in transport activity observed by removing active SPAK from DCT (decreasing NCC activity), but alleviating KS-SPAK inhibition of OSR in
TAL (increasing NKCC2 activity). The model also shows how the SPAK isoform switch, induced by ECF depletion, stimulates transport along TAL and DCT by
reducing the abundance of KS-SPAK in TAL, but increasing the abundance of active kinases in both segments. This model does not show phosphorylation of the
kinases, but this is clearly an essential element of activation.
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SPAK Isoform Switch in the Kidneyincreases in OSR1 abundance along TAL. Figure 6 provides
evidence that OSR1 abundance is not increased by SPAK dele-
tion, a finding similar to that of Rafiqi and colleagues in
SPAKT243A/T243A mice (Rafiqi et al., 2010). Thus, there is little
evidence that SPAK deletion or inactivation itself increases the
abundance of OSR1. A third possibility is that SPAK expressed
by TAL cells acts to suppress rather than stimulate transport;
we suggest that this inhibitory activity is mediated by KS-
SPAK, as this isoform appears to be most abundant along this
segment. Comparison of the current results with those derived
from theSPAKT243A/T243Amiceprovides support for such amodel
(see Figure 7D). When SPAK kinase activity is disrupted but
SPAK abundance is maintained (as in SPAKT243A/T243A mice),
the balance between kinase-inactive SPAK and kinase-active
SPAK reduces the abundance of phosphorylated NKCC2
(Rafiqi et al., 2010); when SPAK is deleted entirely, however,
the inhibitory protein (KS-SPAK) is absent, and the abundance
of phosphorylated NKCC2 rises (Yang et al., 2010). Deletion of
KS-SPAKalong the TAL increasesOSR1phosphorylation in vivo.
We suggest that this occurs because KS-SPAK normally acts
along the TAL to inhibit OSR1 phosphorylation (see Figure 6D).
Thismodel (Figure 7D) also accounts for the effect of SPAKKO
along the DCT, where decreased rather than increased NCC
activity is observed. Along DCT, most SPAK appears to be
kinase active (Figure 2); deleting it reduces NCC phosphoryla-360 Cell Metabolism 14, 352–364, September 7, 2011 ª2011 Elsevietion. As noted (Figure 7), ECF volume depletion shifts SPAK
isoforms away from short products (such as KS-SPAK) and
toward full-length products, favoring SPAK-mediated phosphor-
ylation (Figure 7D); whether this shift occurs uniformly along
the TAL and DCT remains to be established. Possible mediators
of the switch include angiotensin II and arginine vasopressin
(Mutig et al., 2010; van der Lubbe et al., 2011; Welker et al.,
2008), but not aldosterone, as SPAK KO animals exhibit reduced
plasma aldosterone levels. The reduced aldosterone levels may
reflect SPAK-mediated regulation of aldosterone secretion, as
adrenal glands express SPAK abundantly (Delpire and Gagnon,
2008).
This renal-specific expression of a kinase-deficient truncated
product is strikingly reminiscent of the renal-specific expression
of KS-WNK1, a kinase-defective WNK1 isoform, along the distal
nephron that modulates NCC activity both in vitro (Subramanya
et al., 2006) and in vivo (Hadchouel et al., 2010; Liu et al., 2009).
This protein inhibits the kinase activity of WNK1 (Lazrak et al.,
2006; Subramanya et al., 2006; Wade et al., 2006), acting as
a molecular switch in the distal nephron. One interesting differ-
ence between KS-WNK1 and KS-SPAK is that the former
appears to be modulated primarily by dietary KCl intake (Lazrak
et al., 2006; Wade et al., 2006), whereas the latter is modulated
strongly by ECF volume (Figure 7); although effects of KCl intake
on KS-SPAK have yet to be tested directly, this raises ther Inc.
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SPAK Isoform Switch in the Kidneypossibility that interactions between WNK kinases and SPAK/
OSR1 are instrumental in balancing NaCl and K excretion.
These data also illuminate mechanisms by which the WNK/
SPAK/OSR1 signaling complex modulates NCC activity. To
transport NaCl, NCC must be inserted into the apical membrane
and also be phosphorylated (activated). In vitro, NCC trafficking
can be dissociated from NCC phosphorylation (Glover et al.,
2009), but the relationship between the two processes in vivo
has remained obscure. There is strong evidence that NCC is in-
serted into and removed from the apical membrane in response
to physiological need (Lee et al., 2009; Sandberg et al., 2006,
2007); as noted, there is also evidence that NCCphosphorylation
can be regulated under many of the same circumstances. In the
case of SPAK deletion, NCC remains predominantly apical, even
though phosphorylation is largely abrogated by SPAK deletion;
this result is reminiscent of the effects of SORLA KO on
NKCC2; SORLA KO leads to a redistribution of SPAK away
from the plasma membrane, but NKCC2 remains strictly apical.
Thus, NCC activation likely reflects two distinct processes: traf-
ficking to the apical membrane and activation by phosphoryla-
tion, perhaps within the apical membrane.
As reported previously, SPAK KO mice recapitulate many
features that occur when NCC is disrupted genetically, either in
mice or Gitelman patients. These features include hypokalemia,
hypomagnesemia, and hypocalciuria (Schultheis et al., 1998;
Simon et al., 1996). Hypokalemia is a cardinal feature of Gitelman
syndrome; although the tendency for SPAK KOmice to be hypo-
kalemic did not reach significance at baseline, moderate dietary
potassium depletion led to greater hypokalemia in SPAK KO
animals than in WT mice. Similarly, dietary K+ depletion was
required for NCC KO mice to develop hypokalemia (Morris
et al., 2006; Schultheis et al., 1998). The trend to hypomagne-
semia observed in the SPAK KO animals is likely the result of
a deficiency in Trpm6, owing to atrophy or underdevelopment
of the DCT, its predominant site of expression (Nijenhuis et al.,
2005); it is also consistent with the observation that profound
magnesium wasting does not typically occur when humans are
treated with thiazide diuretics. Thiazides have not been reported
to lead to distal atrophy when administered to humans (Ellison
and Loffing, 2009). The observation that dietary NaCl loading
did not normalize calcium excretion in SPAK KO animals
supports the suggestion of Belge and colleagues (Belge et al.,
2007) that both distal and proximal effects contribute to thia-
zide-induced hypocalciuria. Notably, the increased abundance
of p-NKCC2 observed in the SPAK KO animals is mimicked by
an increase in p-NKCC2 in NCC KO animals. Thus, in both cases
(and, we presume, in patients with Gitelman syndrome), the
tendency toward salt wasting is attenuated by activation of
NKCC2 along the TAL.
Although the focus of the present work was not OSR1, the
results do provide insight into the role of OSR1. OSR1 is ex-
pressed along both DCT and TAL, and differential OSR1 isoform
expression was not detected. We have suggested that SPAK
deletion activates NKCC2 by activating OSR1. Yet OSR1 is
also expressed by DCT, whereas SPAK KO has the opposite
effect. We suggest that the opposite effects reflect differing
ratios of KS-SPAK to SPAK or OSR1 along TAL and DCT (also
perhaps between medullary and cortical TAL segments). It is
noteworthy, however, that SPAK deletion leads to the redistribu-Cell Metion of OSR1 only along the DCT to a punctate, intracellular
compartment. The functional consequences of this shift and of
OSR1 in general have not been addressed directly because
targeted disruption of OSR1 is embryonic lethal (Delpire and
Gagnon, 2008), as is knockin of an inactivating T loop mutation
(Rafiqi et al., 2010). Kidney-specific disruption of OSR1 will
provide valuable insight into its role in ion homeostasis and blood
pressure regulation.
In conclusion, the present data provide insight into the
increasingly complexWNK-SPAK/OSR1-NCC/NKCC2 signaling
complex in the kidney. They show that SPAK exerts substantial
effects not only on NCC along the DCT, but also onNKCC2 along
the TAL. They define an isoform switch, which should work to
maintain homeostasis during ECF volume challenge by stimu-
lating NaCl reabsorption along both segments by different
mechanisms. The results also resolve a conundrum with respect
to the divergent effects of SPAK KO and SPAK inactivation
(Rodan and Huang, 2010). Finally, they provide support for the
view that WNK signaling via SPAK/OSR1 to NCC/NKCC2 is
neither unidirectional nor always stimulatory, but is instead
highly recursive and tightly modulated, permitting mammals to
tolerate diets that vary widely in K+ and NaCl.
EXPERIMENTAL PROCEDURES
Animals
Animal studies were approved by the OHSU Institutional Animal Care and
Usage Committee (Protocol A858). Generation of SPAK KO mice has been
reported (Delpire and Gagnon, 2008). Briefly, the SPAK gene was disrupted
by duplicating exon 6 and inserting tyrosinase, neomycin resistance, and 50
hprt genes between the two exons. Animals carrying the mutant allele were
identified by PCR genotyping of tail DNA, and final determination of genotype
was performed by western blotting of kidney protein lysates following
sacrifice.
PCR Genotyping
Crude genomic DNA extracts were prepared from tail snips by heating at 95C
for 45 min in NaOH (pH 12.0), followed by neutralization with Tris-HCl (pH 5.0).
To distinguish mice carrying at least one modified SPAK allele from WT mice,
4 ml of extract was used directly in PCR reactions as described (Delpire and
Gagnon, 2008).
Antibodies
The polyclonal NCC (Bostanjoglo et al., 1998), anti-NKCC2 (Schmitt et al.,
2003), phospho-NKCC2 (Reiche et al., 2010), C-SPAK (Piechotta et al.,
2002), p-T243SPAK/pT185OSR1 (purchased from Division of Signal Trans-
duction Therapy, University of Dundee) (Rafiqi et al., 2010), pS71-NCC
(Yang et al., 2007), and OSR1 (Zago´rska et al., 2007) antibodies have all
been published. The N-SPAK antibody was generated by ligating cDNA corre-
sponding to amino acids 2–74 of mouse SPAK downstream of the GST open
reading frame in the pGEX4 vector. The resulting fusion protein was injected
into rabbits to produce polyclonal antibodies, and the antibody was purified
by incubation with a GST fusion protein column at 4C for 48 hr. After several
washes, the antibody was eluted using 3 ml 100 mM Na-citrate (pH 2.5) and
neutralized with 1.5 ml 1 M Tris-HCl (pH 8.5) and then dialyzed against 4 l
of 13 PBS using a Spectra/Por 12,000–14,000 molecular weight cut-off
(Spectrum Labs, Rancho Dominguez, CA). The affinity-purified antibody was
then concentrated to a volume of 0.5–1 ml using a 15 ml 30,000 MWCO
Amicon Ultra Centrifugal Filter device (Millipore, Danvers, MA). Finally, a small
amount of BSA (1:400 dilution of 20 mg/ml) was added prior to freezing of
aliquots at 20C. This antibody recognized a band of the expected size in
lysates from HEK293 cells (data not shown) and, importantly, on lysates
from WT but not KO animals (see Figure 1D), indicating its high specificity
for the N terminus of SPAK.tabolism 14, 352–364, September 7, 2011 ª2011 Elsevier Inc. 361
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Kidneys were removed, snap frozen in liquid nitrogen, and homogenized in
chilled homogenization buffer containing protease and phosphatase inhibitors
(50 mM Tris-HCl [pH 7.4], 1 mM EDTA, 1 mM EGTA, 0.3 M sucrose, 1 mM
PMSF, 8.5 mM leupeptin, 1 mM orthovanadate, 50 mM Na fluoride, 1 mg/ml
aprotinin, 1 mM dithiothreitol) on ice using a Potter Homogenizer. The homog-
enate was centrifuged at 40003 g for 15 min at 4C, and the supernatant was
separated on 3%–8% NuPage Tris acetate gel at 20 mA. Following transfer to
PVDFmembrane, equal loading was confirmed by staining themembrane with
Ponceau red.Membraneswere cut to allow parallel blottingwith anti-b-actin to
allow normalization. The blot was blocked with Blotto-T (5% nonfat dried milk
in PBS-T) and incubated with the primary antibody for 1 hr, then washed and
incubated with secondary antibody (HRP-coupled, diluted 1:4000, Zymed)
and detected using the Western Lightning kit (Perkin Elmer). Densitometry
using ImageJ software (NIH), normalized to b-actin, was performed to
compare relative protein concentrations.
50 RACE PCR and RT-PCR
50 RACE PCR was performed using the SMARTer RACE cDNA Amplification
Kit (Clontech) according to the manufacturer’s protocol. Primers were:
SPAKRACE6R,50 CCGTGTAACATCACCCCCTGTGGCTAAG;SPAKRACE10R,
50CCTTCTTGGCTCTTTGGGCTATGTCTGGGG. PCR products were A-tailed
and cloned in pGEM-T Easy (Promega), and minipreps were sequenced.
To determine tissue expression of exon 5a-containing transcripts, RT-PCR
was performed using primers against exon 5a (see Figure S1) and
SPAKRACE10R with multitissue panel I (Clontech, Palo Alto, CA) as template.
For brain, which is not part of cDNA panel I, total RNA from mouse brain was
isolated and used in PCR following reverse transcription.
In Vitro Kinase Assay
GST fusion proteins were made by subcloning mouse-derived fragments
into pGex6P-1, followed by induction of protein expression in BL21 cells
(Novagen); the GST moiety was cleaved using PreScission Protease (GE
Healthcare). In vitro kinase assays were performed by combining in a 30 ml
reaction 1 mg of NCC N2-142 or NKCC2 N2-172 and 0.5 mg of a constitutively
active mutant of SPAK (T243E) or OSR1 (T185E) with 0.4, 1.2, 2.4, or 4.8 mg
KS-SPAK in kinase assay buffer (10 mM HEPES [pH 8.0], 10 mM MgCl2,
2 mM benzamidine, 2 mM DTT) with 0.15 mM cold ATP and 10 mCi ATP
g-32P. Reactions were incubated at 30C for 45 min, then stopped by adding
SDS-PAGE sample buffer and boiling for 5 min at 100C. Samples were then
resolved on 4%–12% Bis-tris polyacrylamide gels, Coomassie stained, dried,
and exposed to autoradiographic film.
NCC Phosphorylation in HEK293 Cells
All plasmids were generated by cloning cDNAs into pMO-myc, which uses the
SV40 promoter to drive expression in mammalian cells. HEK293 cells were
plated at a density of 1.753 105 cells/well in 12-well plates. The next day, cells
were transfected with 0.25 mg mouse NCC and increasing amounts of mouse
KS-SPAK (0, 1, 1.5, 2.5, or 5 mg) using calcium phosphate precipitation.
Medium was changed 24 hr later, and cells were harvested in lysis buffer
48 hr posttransfection for western blotting.
Blood Pressure Measurement
Blood pressures were measured using CODA-6 tail cuff blood pressure moni-
toring system (Kent Scientific). The mice were trained prior to the studies by
restraint with 25 cycles of cuff inflation/deflation on 5 consecutive days. On
subsequent days, measurements were made after 5 min of restraint with no
external manipulation or stimulation. Ten acclimation cycles, followed by
fifteen measurement cycles, were performed. Blood pressure measurements
were done for 5 consecutive days on alternating channels of the CODA-6.
When dietary changes were made, 14 days were allowed to pass before
measurements were made. During this time, the blood pressures were
measured 5 days a week to keep mice acclimated to the procedure, but the
data were discarded.
Diuretic Response
Diuretic responseswere determined using amethod previously reported. Mice
maintained on 0.49% NaCl control diet had their bladders emptied via manual362 Cell Metabolism 14, 352–364, September 7, 2011 ª2011 Elseviemassage. Mice were then placed in metabolic cages, and urine was then
collected under water-saturated light mineral oil for 3 hr. Furosemide or
HCTZ (dissolved in 1.7% ethanolamine) was injected intraperitoneally at
25 mg/kg, and a further 3 hr urine collection was performed. Urinary sodium
and creatinine levels were then assayed as described below.
Analysis of Blood Electrolytes
Whole blood was collected via lateral saphenous vein sampling or terminal
cardiac puncture (under anesthesia) and placed into heparinized Eppendorf
tubes. One hundred microliters of whole blood was then immediately added
to a Chem8 cartridge, or 65 ml was added to E3 cartridge and analyzed using
i-STAT analyzer (Abbot Point of Care, Inc.). Plasmamagnesiumwasmeasured
by a colorimetric assay (Pointe Scientific).
Plasma Aldosterone and Renin Activity
Plasma aldosterone levels were measured by ELISA (IBL-America). PRA was
measured as the amount of angiotensin I generated after incubation with
excess angiotensinogen (MP Biomedicals). Two microliters of plasma were
incubated with excess porcine angiotensinogen (4 mM) in a 10 ml reaction con-
taining sodium acetate (50 mM, pH 6.5), AEBSF (2.5 mM), 8-hydroxyquinoline
(1 mM), and EDTA (5 mM) for 15 min at 37C. The assay was linear for at least
30 min. The reaction was stopped by boiling for 5 min and diluted 1:50, and
angiotensin I was measured by ELISA (Phoenix Pharmaceuticals).
Analysis of Urine
For calcium determination, spot urine samples were collected by placing mice
in a cleanmetabolic cage until themice spontaneously voided. Urinary calcium
was measured by o-Cresolphthalein Complexone method (Pointe Scientific),
according to the manufacturer’s protocol, except that samples were diluted
1:2. Urinary creatinine was measured by modified Jaffe method (Pointe Scien-
tific) on samples diluted 1:10. Urinary calcium:creatinine ratios were calculated
from this data. Urinary sodium in samples obtained in the diuretic response
study was measured by flame photometry.
Dietary Manipulation
Custom research diets with varying NaCl levels (0.01%, 0.49%, and 8% NaCl)
and potassium-deficient diet (Harlan Teklad) were used. Mice aged 3–
4months were placed on control diet (0.49%NaCl, 0.8% K+) or NaCl-deficient
diet and subjected to blood pressure, urinary, and plasma electrolyte analysis.
The diet was then changed to the other diet, and blood pressure, urinary, and
plasma electrolyte analysis was performed after 7–14 days, followed by har-
vesting of kidneys. Mice were placed on high-NaCl diet for 2 weeks, and
spot urine was collected, followed by cardiac puncture with electrolyte anal-
ysis and harvesting of kidneys.
Immunofluorescence
Mice were anesthetized and kidneys perfusion-fixed by retrograde abdominal
aortic perfusion of 3% paraformaldehyde in PBS (pH 7.4). After cryoprotection
with 30%sucrose and freezing, 5 mmsectionswere cut, washed in 13PBS33,
incubated in 13 PBS with 0.5%Triton X for 30 min, washed in PBS, and
blocked in 5% milk in PBS for 1 hr. Primary antibody (1:500) in 5% milk in
13 PBS was added for 1 hr, followed by a wash in PBS. Sections were incu-
bated for 1 hr with 1:500 FITC-conjugated secondary antibody (Zymed) in
block, then washed.
Morphometric Procedures
The fractional volume of DCT segments among strains was measured by light
microscopy according to previously characterized methods (Ellison et al.,
1989). Briefly, 5 mm-thick paraffin sections were stained for NCC to identify
DCT. Cortical areas extending between the renal capsule and the outer medul-
lary boundary were evaluated. Sections were photographed and printed at
a final magnification of 3100. At least five prints per animal were evaluated.
Statistical Analyses
Data were analyzed using SPSS (Version 17.0, Chicago, IL). All values are ex-
pressed as means ± standard error of the mean. If a Kolmogorov-Smirnov test
indicated that data were normally distributed, data were analyzed using anal-
ysis of variance (ANOVA) and, if significant, a least-significant-difference postr Inc.
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SPAK Isoform Switch in the Kidneyhoc test. Alternatively, data were analyzed using a Kruskal-Wallis (nonpara-
metric) test or a Mann-Whitney U test, as indicated in the figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and two tables and can be
found with this article online at doi:10.1016/j.cmet.2011.07.009.
ACKNOWLEDGMENTS
This work was supported by grants from the NIH (K01 DK076617 to J.A.M. and
DK51496 to D.H.E.), the Department of Veterans Affairs (Merit Review to
D.H.E.), and the American Heart Association (to D.H.E.). E.J.H. is supported
by an Erasmus MC Fellowship and by the Dutch Kidney Foundation (KJPB
08.004). J.H.N was supported by NIDDK 1T32 DK067864. Prior support
from the American Society of Nephrology to D.H.E. is also acknowledged.
We also acknowledge Nicole Desmarais for technical assistance.
Received: February 25, 2011
Revised: June 9, 2011
Accepted: July 29, 2011
Published: September 6, 2011
REFERENCES
Anselmo, A.N., Earnest, S., Chen, W., Juang, Y.C., Kim, S.C., Zhao, Y., and
Cobb, M.H. (2006). WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter
in HeLa cells. Proc. Natl. Acad. Sci. USA 103, 10883–10888.
Belge, H., Gailly, P., Schwaller, B., Loffing, J., Debaix, H., Riveira-Munoz, E.,
Beauwens, R., Devogelaer, J.P., Hoenderop, J.G., Bindels, R.J., and
Devuyst, O. (2007). Renal expression of parvalbumin is critical for NaCl
handling and response to diuretics. Proc. Natl. Acad. Sci. USA 104, 14849–
14854.
Bostanjoglo, M., Reeves, W.B., Reilly, R.F., Vela´zquez, H., Robertson, N.,
Litwack, G., Morsing, P., Dørup, J., Bachmann, S., and Ellison, D.H. (1998).
11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and
thiazide-sensitive Na-Cl cotransporter expression by distal tubules. J. Am.
Soc. Nephrol. 9, 1347–1358.
Delpire, E., and Gagnon, K.B. (2008). SPAK and OSR1: STE20 kinases
involved in the regulation of ion homoeostasis and volume control in mamma-
lian cells. Biochem. J. 409, 321–331.
Dowd, B.F., and Forbush, B. (2003). PASK (proline-alanine-rich STE20-related
kinase), a regulatory kinase of the Na-K-Cl cotransporter (NKCC1). J. Biol.
Chem. 278, 27347–27353.
Ellison, D.H., and Loffing, J. (2009). Thiazide effects and adverse effects:
insights from molecular genetics. Hypertension 54, 196–202.
Ellison, D.H., Vela´zquez, H., and Wright, F.S. (1989). Adaptation of the distal
convoluted tubule of the rat. Structural and functional effects of dietary salt
intake and chronic diuretic infusion. J. Clin. Invest. 83, 113–126.
Feng, M., Whitesall, S., Zhang, Y., Beibel, M., D’Alecy, L., and DiPetrillo, K.
(2008). Validation of volume-pressure recording tail-cuff blood pressure
measurements. Am. J. Hypertens. 21, 1288–1291.
Geng, Y., Byun, N., and Delpire, E. (2010). Behavioral analysis of Ste20 kinase
SPAK knockout mice. Behav. Brain Res. 208, 377–382.
Glover, M., Zuber, A.M., and O’Shaughnessy, K.M. (2009). Renal and brain
isoforms of WNK3 have opposite effects on NCCT expression. J. Am. Soc.
Nephrol. 20, 1314–1322.
Hadchouel, J., Soukaseum, C., Bu¨sst, C., Zhou, X.O., Baudrie, V., Zu¨rrer, T.,
Cambillau, M., Elghozi, J.L., Lifton, R.P., Loffing, J., and Jeunemaitre, X.
(2010). Decreased ENaC expression compensates the increased NCC activity
following inactivation of the kidney-specific isoform of WNK1 and prevents
hypertension. Proc. Natl. Acad. Sci. USA 107, 18109–18114.
Lazrak, A., Liu, Z., and Huang, C.L. (2006). Antagonistic regulation of ROMK
by long and kidney-specific WNK1 isoforms. Proc. Natl. Acad. Sci. USA 103,
1615–1620.Cell MeLee, D.H., Riquier, A.D., Yang, L.E., Leong, P.K., Maunsbach, A.B., and
McDonough, A.A. (2009). Acute hypertension provokes acute trafficking of
distal tubule Na-Cl cotransporter (NCC) to subapical cytoplasmic vesicles.
Am. J. Physiol. Renal Physiol. 296, F810–F818.
Liu, Z., Wang, H.R., and Huang, C.L. (2009). Regulation of ROMK channel
and K+ homeostasis by kidney-specific WNK1 kinase. J. Biol. Chem. 284,
12198–12206.
Mayan, H., Vered, I., Mouallem, M., Tzadok-Witkon, M., Pauzner, R., and
Farfel, Z. (2002). Pseudohypoaldosteronism type II: marked sensitivity to
thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
J. Clin. Endocrinol. Metab. 87, 3248–3254.
Morris, R.G., Hoorn, E.J., and Knepper, M.A. (2006). Hypokalemia in a mouse
model of Gitelman’s syndrome. Am. J. Physiol. Renal Physiol. 290, F1416–
F1420.
Mutig, K., Saritas, T., Uchida, S., Kahl, T., Borowski, T., Paliege, A., Bo¨hlick, A.,
Bleich, M., Shan, Q., and Bachmann, S. (2010). Short-term stimulation of the
thiazide-sensitive Na+-Cl- cotransporter by vasopressin involves phosphory-
lation and membrane translocation. Am. J. Physiol. Renal Physiol. 298,
F502–F509.
Nijenhuis, T., Vallon, V., van der Kemp, A.W., Loffing, J., Hoenderop, J.G., and
Bindels, R.J. (2005). Enhanced passive Ca2+ reabsorption and reducedMg2+
channel abundance explains thiazide-induced hypocalciuria and hypomagne-
semia. J. Clin. Invest. 115, 1651–1658.
Piechotta, K., Lu, J., and Delpire, E. (2002). Cation chloride cotransporters
interact with the stress-related kinases Ste20-related proline-alanine-rich
kinase (SPAK) and oxidative stress response 1 (OSR1). J. Biol. Chem. 277,
50812–50819.
Piechotta, K., Garbarini, N., England, R., and Delpire, E. (2003).
Characterization of the interaction of the stress kinase SPAK with the Na+-
K+-2Cl- cotransporter in the nervous system: evidence for a scaffolding role
of the kinase. J. Biol. Chem. 278, 52848–52856.
Rafiqi, F.H., Zuber, A.M., Glover, M., Richardson, C., Fleming, S., Jovanovic,
S., Jovanovic, A., O’Shaughnessy, K.M., and Alessi, D.R. (2010). Role of the
WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol. Med.
2, 63–75.
Reiche, J., Theilig, F., Rafiqi, F.H., Carlo, A.S., Militz, D., Mutig, K., Todiras, M.,
Christensen, E.I., Ellison, D.H., Bader, M., et al. (2010). SORLA/SORL1
functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-)
cotransporter 2. Mol. Cell. Biol. 30, 3027–3037.
Richardson, C., and Alessi, D.R. (2008). The regulation of salt transport and
blood pressure by the WNK-SPAK/OSR1 signalling pathway. J. Cell Sci.
121, 3293–3304.
Richardson, C., Sakamoto, K., de los Heros, P., Deak, M., Campbell, D.G.,
Prescott, A.R., and Alessi, D.R. (2011). Regulation of the NKCC2 ion cotrans-
porter by SPAK-OSR1-dependent and -independent pathways. J. Cell Sci.
124, 789–800.
Rodan, A.R., and Huang, C.L. (2010). An emerging role for SPAK in NCC,
NKCC, and blood pressure regulation. J. Am. Soc. Nephrol. 21, 1812–1814.
Sandberg, M.B., Maunsbach, A.B., and McDonough, A.A. (2006).
Redistribution of distal tubule Na+-Cl- cotransporter (NCC) in response to
a high-salt diet. Am. J. Physiol. Renal Physiol. 291, F503–F508.
Sandberg, M.B., Riquier, A.D., Pihakaski-Maunsbach, K., McDonough, A.A.,
and Maunsbach, A.B. (2007). ANG II provokes acute trafficking of distal tubule
Na+-Cl(-) cotransporter to apical membrane. Am. J. Physiol. Renal Physiol.
293, F662–F669.
Schmitt, R., Klussmann, E., Kahl, T., Ellison, D.H., and Bachmann, S. (2003).
Renal expression of sodium transporters and aquaporin-2 in hypothyroid
rats. Am. J. Physiol. Renal Physiol. 284, F1097–F1104.
Schultheis, P.J., Lorenz, J.N., Meneton, P., Nieman, M.L., Riddle, T.M.,
Flagella, M., Duffy, J.J., Doetschman, T., Miller, M.L., and Shull, G.E. (1998).
Phenotype resembling Gitelman’s syndrome in mice lacking the apical Na+-
Cl- cotransporter of the distal convoluted tubule. J. Biol. Chem. 273, 29150–
29155.tabolism 14, 352–364, September 7, 2011 ª2011 Elsevier Inc. 363
Cell Metabolism
SPAK Isoform Switch in the KidneySimon, D.B., Nelson-Williams, C., Bia, M.J., Ellison, D., Karet, F.E., Molina,
A.M., Vaara, I., Iwata, F., Cushner, H.M., Koolen, M., et al. (1996). Gitelman’s
variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by
mutations in the thiazide-sensitive Na-Cl cotransporter. Nat. Genet. 12, 24–30.
Subramanya, A.R., Yang, C.L., Zhu, X., and Ellison, D.H. (2006). Dominant-
negative regulation of WNK1 by its kidney-specific kinase-defective isoform.
Am. J. Physiol. Renal Physiol. 290, F619–F624.
van der Lubbe, N., Lim, C.H., Fenton, R.A., Meima, M.E., Jan Danser, A.H.,
Zietse, R., and Hoorn, E.J. (2011). Angiotensin II induces phosphorylation of
the thiazide-sensitive sodium chloride cotransporter independent of aldoste-
rone. Kidney Int. 79, 66–76.
Vitari, A.C., Deak, M., Morrice, N.A., and Alessi, D.R. (2005). The WNK1 and
WNK4 protein kinases that are mutated in Gordon’s hypertension syndrome
phosphorylate and activate SPAK and OSR1 protein kinases. Biochem. J.
391, 17–24.
Wade, J.B., Fang, L., Liu, J., Li, D., Yang, C.L., Subramanya, A.R., Maouyo, D.,
Mason, A., Ellison, D.H., and Welling, P.A. (2006). WNK1 kinase isoform
switch regulates renal potassium excretion. Proc. Natl. Acad. Sci. USA 103,
8558–8563.364 Cell Metabolism 14, 352–364, September 7, 2011 ª2011 ElsevieWelker, P., Bo¨hlick, A., Mutig, K., Salanova, M., Kahl, T., Schlu¨ter, H., Blottner,
D., Ponce-Coria, J., Gamba, G., and Bachmann, S. (2008). Renal Na+-K+-Cl-
cotransporter activity and vasopressin-induced trafficking are lipid raft-depen-
dent. Am. J. Physiol. Renal Physiol. 295, F789–F802.
Wilson, F.H., Disse-Nicode`me, S., Choate, K.A., Ishikawa, K., Nelson-
Williams, C., Desitter, I., Gunel, M., Milford, D.V., Lipkin, G.W., Achard, J.M.,
et al. (2001). Human hypertension caused by mutations in WNK kinases.
Science 293, 1107–1112.
Yang, S.S., Morimoto, T., Rai, T., Chiga, M., Sohara, E., Ohno, M., Uchida, K.,
Lin, S.H., Moriguchi, T., Shibuya, H., et al. (2007). Molecular pathogenesis
of pseudohypoaldosteronism type II: generation and analysis of a
Wnk4(D561A/+) knockin mouse model. Cell Metab. 5, 331–344.
Yang, S.S., Lo, Y.F., Wu, C.C., Lin, S.W., Yeh, C.J., Chu, P., Sytwu, H.K.,
Uchida, S., Sasaki, S., and Lin, S.H. (2010). SPAK-knockout mice manifest
Gitelman syndrome and impaired vasoconstriction. J. Am. Soc. Nephrol. 21,
1868–1877.
Zago´rska, A., Pozo-Guisado, E., Boudeau, J., Vitari, A.C., Rafiqi, F.H.,
Thastrup, J., Deak, M., Campbell, D.G., Morrice, N.A., Prescott, A.R., and
Alessi, D.R. (2007). Regulation of activity and localization of the WNK1 protein
kinase by hyperosmotic stress. J. Cell Biol. 176, 89–100.r Inc.
